Taiko Pharmaceutical Co (TSE:4574) Other Stockholders Equity : 円607 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Other Stockholders Equity?

Taiko Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Mar. 2024 was 円607 Mil.

Taiko Pharmaceutical Co's quarterly Other Stockholders Equity declined from Sep. 2023 (円555 Mil) to Dec. 2023 (円454 Mil) but then increased from Dec. 2023 (円454 Mil) to Mar. 2024 (円607 Mil).

Taiko Pharmaceutical Co's annual Other Stockholders Equity increased from Mar. 2020 (円109 Mil) to Dec. 2021 (円210 Mil) and increased from Dec. 2021 (円210 Mil) to Dec. 2022 (円309 Mil).

Taiko Pharmaceutical Co Other Stockholders Equity Historical Data

The historical data trend for Taiko Pharmaceutical Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Other Stockholders Equity Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Other Stockholders Equity

Get a 7-Day Free Trial

184.02

147.29

109.38

210.00

309.00

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															330.00	494.00	555.00	454.00	607.00

Taiko Pharmaceutical Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Taiko Pharmaceutical Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines